hVIVO plc Exercise of Share Options (4368Y)
21 Août 2018 - 12:00PM
UK Regulatory
TIDMHVO
RNS Number : 4368Y
hVIVO plc
21 August 2018
HVIVO PLC
("hVIVO" or the "Company")
Exercise of Share Options
London, UK, 21 August 2018: hVIVO plc (AIM: HVO), a pioneer of
human disease models and an industry leading clinical development
services business, announces that, following the exercise of
employee share options, application has been made to AIM for the
admission of 205,540 new ordinary shares of 5.0p each (the "New
Ordinary Shares").
Admission to trading on AIM of the New Ordinary Shares
("Admission"), which will rank pari passu in all respects with the
Company's existing shares in issue, is expected to occur on 28
August 2018.
Following Admission, the total number of ordinary shares with
voting rights in issue will be 79,208,754 and this figure may be
used by shareholders as the denominator for the calculations by
which they will determine if they are required to notify their
interest in, or a change to their interest in, the Company under
the Financial Conduct Authority's Disclosure and Transparency
Rules.
For further information please contact:
hVIVO plc
Trevor Phillips (Executive Chairman) +44 207 756 1300
Fleur Wood (Director, Investor Relations)
Numis Securities Limited +44 207 260 1000
Michael Meade / Freddie Barnfield
(Nominated Adviser)
James Black / Michael Burke (Corporate
Broking)
FTI Consulting
Simon Conway / Victoria Foster Mitchell +44 203 727 1000
Notes to Editors:
hVIVO plc ("hVIVO") is pioneering a human-based analytical
platform to accelerate drug discovery and development in
respiratory and infectious diseases. Leveraging human disease
models in flu, RSV and asthma exacerbation, the hVIVO platform
captures disease in motion, illuminating the entire disease life
cycle from healthy to sick and back to health. Based in the UK,
market leader hVIVO has conducted more than 50 clinical studies,
inoculated over 2500 volunteers and has three first-in-class
therapies currently in development.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
IOELIFSATSILFIT
(END) Dow Jones Newswires
August 21, 2018 06:00 ET (10:00 GMT)
Hvivo (LSE:HVO)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Hvivo (LSE:HVO)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024